Lv3
316 积分 2024-10-14 加入
Radiation-Induced Lymphocyte Apoptosis to Predict Radiation Therapy Late Toxicity in Prostate Cancer Patients
9天前
已完结
A Phase I Clinical Trial of Chimeric Antigen Receptor-Modified T Cells in Patients with Relapsed and Refractory Lymphoma
14天前
已完结
Phase I study of CBM.CD19 chimeric antigen receptor T cell in the treatment of refractory diffuse large B-cell lymphoma in Chinese patients
14天前
已完结
Talicabtagene autoleucel for relapsed or refractory B-cell malignancies: results from an open-label, multicentre, phase 1/2 study
14天前
已完结
Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial
14天前
已完结
A Phase I First-in-Human Clinical Trial of CD19-Targeted 19-28z/4-1BBL "Armored" CAR T Cells in Patients with Relapsed or Refractory NHL and CLL Including Richter's Transformation
14天前
已完结
Modulation of cellular processes by histone and non-histone protein acetylation
1个月前
已完结
Programming CAR-T cells to kill cancer
2个月前
已完结
Long-term outcomes following CAR T cell therapy: what we know so far
2个月前
已完结
Mitochondrial Biomass As a Measure of Fitness for T Cells Expressing Chimeric Antigen Receptors
2个月前
已关闭
皖公网安备34019202002308
